Advertisement Pressure BioSciences and JCVI sign collaboration agreement - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Pressure BioSciences and JCVI sign collaboration agreement

Pressure BioSciences, a life sciences company, has entered into a collaboration with the J Craig Venter Institute, a not-for-profit genomic research institute, with facilities in Rockville, Maryland and La Jolla, California.

As part of the collaboration, the J Craig Venter Institute (JCVI) has purchased a Barocycler NEP2320 PCT sample preparation system. The company also announced that it has sold two Barocycler NEP3229 PCT sample preparation systems to a global biopharmaceutical company.

JCVI will be using Pressure BioSciences’s (PBI) pressure cycling technology (PCT) and sample preparation platform as part of the collaboration. To that end, JCVI has purchased a Barocycler NEP2320 PCT sample preparation system, and intends to further develop PCT into JCVI’s extraction protocols.

In addition to this purchase, PBI will provide JCVI with two additional instruments for further studies as part of the collaboration. Among the projects for which PBI’s technology will be used is JCVI’s National Institutes of Health-funded human microbiome project, where JCVI scientists are discovering and cataloging the microbes that live on and in the human body.

Matthew Potter, vice president of sales at Pressure BioSciences, said: We are excited that the J Craig Venter Institute, with their purchase of a PCT system, has recognized the potential of PCT to improve the extraction of proteins and nucleic acids from biological samples, a key step in laboratory research. We are also pleased to have the opportunity to collaborate with the JCVI in their microbiome project.